Soleus Private Equity Fund III L.P. 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 4:15 pm Sale |
2023-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
Soleus Private Equity Fund III L.P. | 1,820,365 9.990% |
-47,690 (-2.55%) |
Filing |
| 2023-10-26 5:00 pm Purchase |
2023-10-25 | 13G | Harpoon Therapeutics, Inc. HARP |
Soleus Private Equity Fund III L.P. | 1,868,055 9.990% |
1,868,055 (New Position) |
Filing |